Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Jordan

Showing results (451-460 of 1,874) with videos related to

Pageof 188
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1995
Endometrial carcinoma and tamoxifen: clearing up a controversyV C Jordan, V J Assikis
Heredity|November 4, 1998
New perspectives on mate choice and the MHCW C Jordan, M W Bruford
Molecular Medicine Today|May 1, 1996
Targeted anti-estrogens to treat and prevent diseases in womenD A Tonetti, V C Jordan
Seminars in Surgical Oncology|September 1, 1996
Is it time to develop an optimal endocrine therapy for premenopausal patients with axillary node positive and negative breast cancer?M M Bilimoria, V C Jordan
Endocrinology|December 1, 1980
Modulation of rat uterine steroid hormone receptors by estrogen and antiestrogenC J Dix, V C Jordan
British Journal of Pharmacology|November 1, 1978
The antitumour activity of tamoxifen and monohydroxytamoxifen: a comparative study in the rat [proceedings]V C Jordan, K E Naylor
British Journal of Pharmacology|August 1, 1976
Oestrogenic, anti-oestrogenic and fertility effects of some triphenylethanes and triphenylethylenes related to ethamoxytriphetol (MER 25)E R Clark, V C Jordan
Cancer Treatment and Research|May 20, 1998
The duration of adjuvant tamoxifen therapyM M Bilimoria, V C Jordan
The Journal of Endocrinology|June 1, 1980
Subcellular effects of monohydroxytamoxifen in the rat uterus: steroid receptors and mitosisC J Dix, V C Jordan
Pharmacology & Therapeutics|January 1, 1988
Metabolism of steroid-modifying anticancer agentsS P Robinson, V C Jordan
Pageof 188

Showing results (451-460 of 1,874) with videos related to

Sort By:
Pageof 188
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1995
Endometrial carcinoma and tamoxifen: clearing up a controversyV C Jordan, V J Assikis
Heredity|November 4, 1998
New perspectives on mate choice and the MHCW C Jordan, M W Bruford
Molecular Medicine Today|May 1, 1996
Targeted anti-estrogens to treat and prevent diseases in womenD A Tonetti, V C Jordan
Seminars in Surgical Oncology|September 1, 1996
Is it time to develop an optimal endocrine therapy for premenopausal patients with axillary node positive and negative breast cancer?M M Bilimoria, V C Jordan
Endocrinology|December 1, 1980
Modulation of rat uterine steroid hormone receptors by estrogen and antiestrogenC J Dix, V C Jordan
British Journal of Pharmacology|November 1, 1978
The antitumour activity of tamoxifen and monohydroxytamoxifen: a comparative study in the rat [proceedings]V C Jordan, K E Naylor
British Journal of Pharmacology|August 1, 1976
Oestrogenic, anti-oestrogenic and fertility effects of some triphenylethanes and triphenylethylenes related to ethamoxytriphetol (MER 25)E R Clark, V C Jordan
Cancer Treatment and Research|May 20, 1998
The duration of adjuvant tamoxifen therapyM M Bilimoria, V C Jordan
The Journal of Endocrinology|June 1, 1980
Subcellular effects of monohydroxytamoxifen in the rat uterus: steroid receptors and mitosisC J Dix, V C Jordan
Pharmacology & Therapeutics|January 1, 1988
Metabolism of steroid-modifying anticancer agentsS P Robinson, V C Jordan
Pageof 188